Cargando…
“Data safety and monitoring board in non-industry trials: learning it the hard way”
Autores principales: | Hazenberg, A., Kerstjens, H. A. M., Wijkstra, P. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448558/ https://www.ncbi.nlm.nih.gov/pubmed/26018923 http://dx.doi.org/10.1186/s12931-015-0222-6 |
Ejemplares similares
-
Is chronic ventilatory support really effective in patients with amyotrophic lateral sclerosis?
por: Hazenberg, A., et al.
Publicado: (2016) -
Facioscapulohumeral muscular dystrophy and respiratory failure; what about the diaphragm?
por: Hazenberg, A., et al.
Publicado: (2014) -
Importance of swift event adjudication of endpoints for adequate reporting to data and safety monitoring boards in clinical trials—lessons from CULPRIT-SHOCK
por: Clemmensen, Peter, et al.
Publicado: (2021) -
The role of data and safety monitoring boards in implementation trials: When are they justified?
por: Fiscella, Kevin, et al.
Publicado: (2020) -
A simple way to improve the safety of the surgical field
por: Guarneri, G F, et al.
Publicado: (2012)